James W. Dearing ([email protected]) is a professor in the Department of Communication at Michigan State University, in East Lansing. Jeffrey G. Cox is a research associate in the Department of ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics and West Virginia University’s ...

Cognito Motorsports of California's rugged Central Valley has issued a recall that affects 12,160 ball joints. Intended for the 2021 through 2025 model year Chevrolet Silverado HD and the GMC-branded ...

HOPE is evaluating Cognito’s investigative non-invasive neuroprotective therapy to better preserve cognition and function in patients with Alzheimer’s. The study is the largest ever medical device ...

CAMBRIDGE, Mass., February 11, 2025--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a ...

Amazon Web Services (AWS) has announced updates to Amazon Cognito, its identity and access management service for Web and mobile applications. The service allows developers to secure ...

It’s hard to miss how much attention AI image generators alone have attracted in recent months. With good reason, because they demonstrate the progress of deep learning models in a vivid and playful ...

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the ...

As it plows ahead in its efforts to secure an FDA greenlight for its light- and sound-based neuromodulation device to treat Alzheimer’s disease, Cognito Therapeutics is taking an even closer look at ...

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...